|
Name |
Aspernolide K
|
Molecular Formula | C25H26O8 | |
IUPAC Name* |
methyl (2R)-2-[[(3S)-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl]methyl]-3-(4-hydroxyphenyl)-4-methoxy-5-oxofuran-2-carboxylate
|
|
SMILES |
CC1([C@H](CC2=C(O1)C=CC(=C2)C[C@@]3(C(=C(C(=O)O3)OC)C4=CC=C(C=C4)O)C(=O)OC)O)C
|
|
InChI |
InChI=1S/C25H26O8/c1-24(2)19(27)12-16-11-14(5-10-18(16)32-24)13-25(23(29)31-4)20(21(30-3)22(28)33-25)15-6-8-17(26)9-7-15/h5-11,19,26-27H,12-13H2,1-4H3/t19-,25+/m0/s1
|
|
InChIKey |
KIXPVRZDVZKIHJ-UQBPGWFLSA-N
|
|
Synonyms |
Aspernolide K; CHEMBL4211465; methyl (2R)-2-[[(3S)-3-hydroxy-2,2-dimethyl-chroman-6-yl]methyl]-3-(4-hydroxyphenyl)-4-methoxy-5-oxo-furan-2-carboxylate
|
|
CAS | NA | |
PubChem CID | 134816409 | |
ChEMBL ID | CHEMBL4211465 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 454.5 | ALogp: | 3.1 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 112.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 33 | QED Weighted: | 0.662 |
Caco-2 Permeability: | -4.972 | MDCK Permeability: | 0.00002660 |
Pgp-inhibitor: | 0.328 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.931 |
30% Bioavailability (F30%): | 0.978 |
Blood-Brain-Barrier Penetration (BBB): | 0.377 | Plasma Protein Binding (PPB): | 98.55% |
Volume Distribution (VD): | 0.516 | Fu: | 2.22% |
CYP1A2-inhibitor: | 0.629 | CYP1A2-substrate: | 0.798 |
CYP2C19-inhibitor: | 0.941 | CYP2C19-substrate: | 0.443 |
CYP2C9-inhibitor: | 0.933 | CYP2C9-substrate: | 0.293 |
CYP2D6-inhibitor: | 0.847 | CYP2D6-substrate: | 0.228 |
CYP3A4-inhibitor: | 0.947 | CYP3A4-substrate: | 0.825 |
Clearance (CL): | 9.474 | Half-life (T1/2): | 0.665 |
hERG Blockers: | 0.195 | Human Hepatotoxicity (H-HT): | 0.763 |
Drug-inuced Liver Injury (DILI): | 0.92 | AMES Toxicity: | 0.032 |
Rat Oral Acute Toxicity: | 0.333 | Maximum Recommended Daily Dose: | 0.927 |
Skin Sensitization: | 0.089 | Carcinogencity: | 0.416 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.081 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002900 | 0.845 | D0Q9ON | 0.300 | ||||
ENC002561 | 0.686 | D06TJJ | 0.283 | ||||
ENC003113 | 0.642 | D08CCE | 0.269 | ||||
ENC003497 | 0.619 | D04UTT | 0.261 | ||||
ENC003493 | 0.619 | D06HBQ | 0.260 | ||||
ENC002376 | 0.604 | D07MGA | 0.256 | ||||
ENC003410 | 0.569 | D01XBA | 0.250 | ||||
ENC003597 | 0.565 | D0Q0PR | 0.250 | ||||
ENC003721 | 0.541 | D06GCK | 0.250 | ||||
ENC002729 | 0.530 | D0R1RS | 0.250 |